Gentel Biosciences to Debut Simian Pathogen Detection, Cancer-Testis Antigen Kits Next Month

Gentel plans to add 50 new kits to its product portfolio by the end of the year, as it transforms itself from being a services-oriented business to one that derives the bulk of its sales from products.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.